Comvita Bilan de santé

Santé financière contrôle des critères 3/6

Comvita possède un total de capitaux propres de NZ$160.6M et une dette totale de NZ$87.9M, ce qui porte son ratio d'endettement à 54.7%. Son actif total et son passif total sont NZ$307.9M et de NZ$147.2M.

Informations clés

54.7%

Ratio d'endettement

NZ$87.86m

Dette

Ratio de couverture des intérêts	n/a
Argent liquide	NZ$8.16m
Fonds propres	NZ$160.63m
Total du passif	NZ$147.23m
Total des actifs	NZ$307.86m

Mises à jour récentes de la santé financière

Here's Why Comvita (NZSE:CVT) Is Weighed Down By Its Debt Load

Mar 21

These 4 Measures Indicate That Comvita (NZSE:CVT) Is Using Debt Reasonably Well

Mar 25

Recent updates

Here's Why Comvita (NZSE:CVT) Is Weighed Down By Its Debt Load

Mar 21

Comvita Limited's (NZSE:CVT) 26% Dip In Price Shows Sentiment Is Matching Earnings

Feb 05

How Much Did Comvita's(NZSE:CVT) Shareholders Earn From Share Price Movements Over The Last Three Years?

Dec 22

Could The Comvita Limited (NZSE:CVT) Ownership Structure Tell Us Something Useful?

Nov 25

Analyse de la situation financière

Passif à court terme: Les actifs à court terme de CVT ( NZ$192.9M ) dépassent ses passifs à court terme ( NZ$130.5M ).

Passif à long terme: Les actifs à court terme de CVT ( NZ$192.9M ) dépassent ses passifs à long terme ( NZ$16.7M ).

Historique et analyse du ratio d'endettement

Niveau d'endettement: Le ratio dette nette/capitaux propres de CVT ( 49.6% ) est considéré comme élevé.

Réduire la dette: Le ratio d'endettement de CVT a été réduit de 57.3% à 54.7% au cours des 5 dernières années.

Couverture de la dette: La dette de CVT n'est pas bien couverte par le flux de trésorerie opérationnel ( 6.1% ).

Couverture des intérêts: Données insuffisantes pour déterminer si les paiements d'intérêts de CVT sur sa dette sont bien couverts par l'EBIT.

Comvita Bilan de santé

Santé financière contrôle des critères 3/6

Informations clés

Mises à jour récentes de la santé financière

Here's Why Comvita (NZSE:CVT) Is Weighed Down By Its Debt Load

These 4 Measures Indicate That Comvita (NZSE:CVT) Is Using Debt Reasonably Well

Recent updates

Comvita Limited, Annual General Meeting, Oct 30, 2024

New major risk - Financial position

Consensus EPS estimates have been downgraded.

Full year 2024 earnings released: NZ$1.10 loss per share (vs NZ$0.16 profit in FY 2023)

Now 30% undervalued after recent price drop

Investor sentiment deteriorates as stock falls 18%

Upcoming dividend of NZ$0.012 per share

Here's Why Comvita (NZSE:CVT) Is Weighed Down By Its Debt Load

First half 2024 earnings released: NZ$0.046 loss per share (vs NZ$0.06 profit in 1H 2023)

Investor sentiment improves as stock rises 21%

Now 28% overvalued

Comvita Limited's (NZSE:CVT) 26% Dip In Price Shows Sentiment Is Matching Earnings

Consensus EPS estimates fall by 46%

New minor risk - Share price stability

Investor sentiment deteriorates as stock falls 16%

Consensus EPS estimates fall by 56%

Price target decreased by 24% to NZ$3.35

A Look At The Fair Value Of Comvita Limited (NZSE:CVT)

Comvita Limited (NZSE:CVT) acquired an additional 12% stake in Apiter Laboratories for $2 million.

Less than half of directors are independent

Comvita Limited Approves the Appointment of Michael Sang as Director

Upcoming dividend of NZ$0.035 per share at 1.7% yield

Key Executive recently sold NZ$379k worth of stock

Consensus EPS estimates fall by 18%

New minor risk - Earnings quality

Comvita Limited Announces Final Fully Imputed Dividend for the Full Year 2023

Full year 2023 earnings: EPS misses analyst expectations

Comvita Limited, Annual General Meeting, Oct 04, 2023

Investor sentiment improves as stock rises 16%

CEO, MD & Director recently sold NZ$86k worth of stock

Upcoming dividend of NZ$0.029 per share at 1.9% yield

Independent Director recently sold NZ$101k worth of stock

Consensus EPS estimates fall by 15%

First half 2023 earnings released: EPS: NZ$0.06 (vs NZ$0.05 in 1H 2022)

Price target increased to NZ$4.50

High number of new directors

Upcoming dividend of NZ$0.035 per share

High number of new directors

Price target increased to NZ$4.50

Comvita Limited Provides Earnings Guidance for the Year 2023

Comvita Limited, Annual General Meeting, Sep 29, 2022

Insider recently bought NZ$63k worth of stock

Upcoming dividend of NZ$0.029 per share

First half 2022 earnings: EPS and revenues miss analyst expectations

Upcoming dividend of NZ$0.047 per share

Price target increased to NZ$3.70

Full year 2021 earnings released: EPS NZ$0.14 (vs NZ$0.19 loss in FY 2020)

Consensus forecasts updated

These 4 Measures Indicate That Comvita (NZSE:CVT) Is Using Debt Reasonably Well

Comvita Launches Special Reserve Manuka and OneHive Movement

We Think Comvita's (NZSE:CVT) Robust Earnings Are Conservative

Is It Too Late To Consider Buying Comvita Limited (NZSE:CVT)?

First half 2021 earnings released: EPS NZ$0.05 (vs NZ$0.26 loss in 1H 2020)

Have Insiders Been Buying Comvita Limited (NZSE:CVT) Shares This Year?

How Much Did Comvita's(NZSE:CVT) Shareholders Earn From Share Price Movements Over The Last Three Years?

New 90-day high: NZ$3.40

Could The Comvita Limited (NZSE:CVT) Ownership Structure Tell Us Something Useful?

Full year earnings released - NZ$0.19 loss per share

Analyse de la situation financière

Historique et analyse du ratio d'endettement

Bilan

Découvrir des entreprises saines